Global Stable Isotope Labeled Compounds - Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Proteomics and Diagnostics Unlock Asia-Pacific Growth

Boost ROI through high-purity fermentation, companion diagnostics, labeled APIs and Asia CRO outsourcing, while securing scarce feedstocks and expanding modular synthesis capacity.


Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "Stable Isotope Labeled Compounds - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The global stable isotope labeled compounds market is estimated at USD 326.71 million in 2026 and is projected to reach USD 386.28 million by 2031, registering a CAGR of 3.41% during the forecast period. Market growth is being supported by rising demand from quantitative proteomics, metabolomics, clinical diagnostics, pharmaceutical research, environmental testing, and regulatory micro-dosing studies.

Quantitative Proteomics and Metabolomics Drive Market Demand

Proteomics and metabolomics laboratories increasingly use stable isotope-labeled amino acids, peptides, and metabolites to achieve highly sensitive measurements in complex biological samples. In 2024, the National Institute of Standards and Technology introduced carbon-13 and nitrogen-15 labeled peptide reference materials, helping laboratories standardize calibration protocols and improve analytical consistency.

Academic research centers and pharmaceutical discovery groups are also requiring larger quantities of uniformly labeled substrates. This trend is encouraging manufacturers to expand fermentation platforms, which can deliver higher isotopic purity than multi-step chemical routes. However, fermentation runs can take up to two weeks, creating challenges when customers require customized compounds within shorter timelines. Suppliers are consequently balancing batch economics, production capacity, isotopic purity, and delivery commitments when planning investments for 2026 and beyond.

Companion Diagnostics Create New Growth Opportunities

Stable isotope-labeled compounds are gaining importance in companion diagnostics and therapeutic drug monitoring. Regulators are approving more isotope-dilution assays for targeted therapies because of their specificity at low biomarker concentrations. In 2025, the FDA cleared several liquid chromatography mass spectrometry tests supported by deuterium or carbon-13 internal standards.

Diagnostic laboratories often select these assays when metabolite interference may reduce the accuracy of immunoassays. Japan's Ministry of Health, Labour and Welfare shortened approval timelines for isotope-based in-vitro diagnostics in 2024, supporting faster commercialization. Reimbursement reforms in the United States and parts of Europe are also strengthening adoption, although cost remains a consideration in emerging economies.

Feedstock Costs and Supply Constraints Affect Expansion

Limited oxygen-18 water availability remains a key restraint for the stable isotope labeled compounds market. Oxygen-18 water can cost more than USD 1,000 per gram at 97% enrichment, while global production capacity remains below 2,000 kilograms annually. Pharmaceutical and environmental laboratories may ration available supplies or shift to deuterium-labeled alternatives during shortages, potentially delaying research programs.

New cryogenic-distillation columns can cost more than USD 50 million and require multi-year permitting, limiting capacity expansion and discouraging market entry. Nitrogen-15 supply is also influenced by enrichment infrastructure and geopolitical conditions. By comparison, deuterium oxide is more widely available, supporting its established use across pharmaceutical analysis and nuclear magnetic resonance spectroscopy.

Isotope and Compound Category Analysis

Deuterium compounds accounted for 42.11% of market revenue in 2025. Their leading position reflects routine use as internal standards in liquid chromatography-mass spectrometry and as solvents in nuclear magnetic resonance spectroscopy. Mature synthesis methods also enable manufacturers to provide deuterium-labeled amino acids, peptides, and small molecules at high purity and comparatively lower cost.

Oxygen-18 labeled materials represent a smaller market segment but are forecast to grow at a 7.02% CAGR through 2031. Demand is being driven by positron-emission tomography tracer production and environmental studies involving per- and polyfluoroalkyl substances.

Amino acids and peptides generated 36.83% of market revenue in 2025, supported by their extensive use in quantitative proteomics. Fermentation platforms can achieve incorporation rates above 99%, making them suitable for kilogram-scale production. Active pharmaceutical ingredients are expected to be the fastest-growing compound category, advancing at a 7.48% CAGR as regulatory acceptance of micro-dosing studies increases. Approximately 15% of investigational new drug applications now specify carbon-13 APIs, encouraging investment in modular synthesis capacity.

Regional Market Outlook

North America held 43.38% of global revenue in 2025, supported by major pharmaceutical operations, mass-spectrometry technology providers, advanced research infrastructure, and established regulatory standards. The Oak Ridge National Laboratory facility commissioned in 2025 restored domestic enrichment capabilities for carbon-13, nitrogen-15, and oxygen-18, reducing reliance on overseas supply. The region is expected to remain a major center for analytical method development and standards setting.

Asia-Pacific is projected to record a 6.04% CAGR through 2031. Regional contract research organizations expanded isotope-synthesis capacity during 2024 and 2025, attracting cost-sensitive pharmaceutical sponsors. Japan remains an important oxygen-18 production center, while evolving bioequivalence guidelines in India are stimulating domestic demand. Licensing reforms in South Korea and Australia may also reduce export-control friction by 2027.

Europe retained a mid-20s percentage share in 2025, led by Germany, the United Kingdom, and France. Updated European Medicines Agency bioanalytical guidelines have improved alignment with FDA standards and supported cross-jurisdiction submissions. Although the Middle East and Africa and South America remain smaller markets, investments in mass-spectrometry diagnostics across Gulf Cooperation Council countries and pharmaceutical quality testing in Brazil are creating additional opportunities.

Other factors shaping the stable isotope labeled compounds market include growing use of 13C-Labelled APIs in regulatory studies, increased biopharma outsourcing to isotope CROs in Asia, and complex export-control requirements for dual-use isotopes.

Key Topics Covered:

1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Quantitative Proteomics & Metabolomics
4.2.2 Expansion of SIL-based Companion Diagnostics
4.2.3 Growing 13C-labelled APIs for Micro-Dosing Regulatory Studies
4.2.4 Heightened Biopharma Outsourcing to Isotope CROs in Asia
4.2.5 Commercialisation of Deep-labeled Reference Standards for PFAS Tracing
4.2.6 Development of Green, Electro-Enzymatic Isotope-Exchange Synthesis
4.3 Market Restraints
4.3.1 High Cost & Limited Availability of 18O-Water Feedstock
4.3.2 Complex Export-Control Regulations for Dual-Use Isotopes
4.3.3 Supply-Chain Sensitivity to Enriched Uranium Tails for 15N
4.3.4 Analytical-Grade Isotope Scarcity for Emerging Ultra-High-Res MS
4.4 Regulatory Landscape
4.5 Technological Outlook
4.6 Porter's Five Forces Analysis
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitutes
4.6.5 Competitive Rivalry

5 Market Size & Growth Forecasts
5.1 By Isotope Type
5.1.1 Deuterium
5.1.2 Carbon-13
5.1.3 Nitrogen-15
5.1.4 Oxygen-18
5.1.5 Others
5.2 By Compound Category
5.2.1 Amino Acids & Peptides
5.2.2 Metabolites & Lipids
5.2.3 Active Pharmaceutical Ingredients
5.2.4 Nucleic Acids
5.2.5 Solvents & Reagents
5.3 By Synthesis Method
5.3.1 Chemical Synthesis
5.3.2 Fermentation & Metabolic Labelling
5.3.3 Enzymatic / Exchange
5.4 By Application
5.4.1 Research (Proteomics, Metabolomics, Flux Analysis)
5.4.2 Clinical Diagnostics
5.4.3 Industrial & Environmental Testing
5.4.4 Other Applications
5.5 By End-User
5.5.1 Pharmaceutical & Biotechnology Companies
5.5.2 Academic & Research Institutes
5.5.3 Hospitals & Diagnostic Centers
5.5.4 Contract Research & Manufacturing Organisations
5.6 By Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 Germany
5.6.2.2 United Kingdom
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East & Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East & Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America

6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Alsachim
6.3.2 Cambridge Isotope Laboratories, Inc.
6.3.3 CDN Isotopes
6.3.4 Euriso-Top
6.3.5 Isoflex
6.3.6 IsoSciences
6.3.7 JSC Isotope
6.3.8 LGC Standards
6.3.9 Medical Isotopes, Inc.
6.3.10 Merck KGaA
6.3.11 Omicron Biochemicals
6.3.12 PerkinElmer Inc
6.3.13 Rotem Industries
6.3.14 Sercon Hylab
6.3.15 Taiwan Advance Nanotech
6.3.16 Taiyo Nippon Sanso
6.3.17 TCI Chemicals
6.3.18 Thermo Fisher Scientific
6.3.19 Toronto Research Chemicals
6.3.20 Trace Sciences International
6.3.21 Urenco Stable Isotopes
6.3.22 Zeochem

7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment

For more information about this report visit https://www.researchandmarkets.com/r/7sw3p9

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Coordonnées

GlobeNewswire